跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
OPUVIZ 40 MG/ML SOLUCION INYECTABLE EN VIAL
Approved
STANDARD
OPUVIZ 40 MG/ML SOLUCION INYECTABLE EN VIAL
Samsung Bioepis Nl B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 29, 2025
Approval ID
2ea21d471a5107bc
Company
Samsung Bioepis Nl B.V.
Type
Standard
Approval Details
Approval Id
2ea21d471a5107bc
Drug Cima Aemps Name
OPUVIZ 40 MG/ML SOLUCION INYECTABLE EN VIAL
Register Number
1241865002
Holder Company Name
Samsung Bioepis Nl B.V.
Marketing Company Name
Samsung Bioepis Nl B.V.
Holder Company Detail Path
/organization/samsung-bioepis-nl-b-v
Marketing Company Detail Path
/organization/samsung-bioepis-nl-b-v
Authorization Date
2025-09-29
Dosage Form
SOLUCIÓN INYECTABLE
Dose
40 mg/ml
Route Of Administration
VÍA INTRAVÍTREA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Samsung Bioepis Nl B.V.
Company Detail Path
/organization/samsung-bioepis-nl-b-v
Company Information
Pharmaceutical Company Name
Samsung Bioepis NL B.V.
Country Name
Netherlands
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 29, 2025
Approval ID
2ea21d471a5107bc
Type
Standard
Back to CIMA-AEMPS Approvals
OPUVIZ 40 MG/ML SOLUCION INYECTABLE EN VIAL - CIMA-AEMPS Drug Approval Details
